Navigation Links
Cystic fibrosis patients may breathe easier, thanks to bioengineered antimicrobials
Date:9/25/2007

CHAMPAIGN, Ill. By better understanding how antimicrobials bind and thereby get inactivated in the mucus of air passages, researchers at the University of Illinois may have found a way to help cystic fibrosis patients fight off deadly infections.

While not a cure, this work has potential as a therapeutic strategy against bacterial infections in cystic fibrosis, said Gerard Wong a professor of materials science and engineering, of physics, and of bioengineering at the U. of I., and a corresponding author of a paper accepted for publication in the Proceedings of the National Academy of Sciences. The paper is to be posted this week on the journals Web site.

Ordinarily, pulmonary passages are lined with a thin layer of mucus that traps bacteria and other pathogens. Moved along by the motions of countless cilia, the mucus also acts as a conveyor belt that disposes of the debris. In patients with cystic fibrosis, however, the mucus is more like molasses thick and viscous. Because the cilia can no longer move the mucus, the layer becomes stuck, and the bacteria grow, multiply and colonize. Long-term bacterial infections are the primary cause of death in cystic fibrosis.

Using synchrotron X-ray scattering and molecular dynamics simulations, the researchers took a closer look at the mucous mess.

Debris in the infected mucus includes negatively charged, long-chained molecules such as mucin, DNA and actin (from dead white blood cells). It turns out most of the bodys antimicrobials, such as lysozyme, are positively charged.

We found that actin and lysozyme two of the most common components in infected mucus form ordered bundles of aligned molecules, which is something you dont expect in something as messy as mucus, said Wong, who also is a researcher at the universitys Beckman Institute. Held together tightly by the attraction of opposite charge, these bundles basically lock up the antimicrobials so that they are unable to kill bacteria.

The re
'/>"/>

Contact: James E. Kloeppel
kloeppel@uiuc.edu
217-244-1073
University of Illinois at Urbana-Champaign
Source:Eurekalert

Page: 1 2

Related biology news :

1. Scientists discover basic defect in cystic fibrosis airway glands
2. Study reveals how cells destroy faulty proteins in cystic fibrosis
3. Discovery could aid fight against cystic fibrosis infection
4. Clues to gene expression in cystic fibrosis will guide research
5. Key found to kill cystic fibrosis superbug
6. Penn study on lung-infecting bacterial enzyme suggests new approach to cystic fibrosis treatment
7. Gene expression patterns predict rapid decline in idiopathic pulmonary fibrosis patients
8. Extra-aggressive form of idiopathic pulmonary fibrosis identified
9. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
10. HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs
11. Emory Eye Center Implants Its First Retinal Chips In Patients With Retinitis Pigmentosa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2015)... , February 11, 2015 ... research report "Access Control Market by Product (Cards and ... Residential, Military and Defense, Government, Industrial, Healthcare, Education) and ... published by MarketsandMarkets, the Access Control Market ... 2020, growing at a CAGR of 10.6% ...
(Date:2/5/2015)... , 5. Februar 2015 Marken ... Logistikunternehmen und hat eine neue Marketingkampagne gestartet, ... (Clinical Logistics Organization – CLO) der Branche ... lautet First , mit Schwerpunkt auf ... http://photos.prnewswire.com/prnh/20150205/173753 Logo - ...
(Date:2/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announces the ... as part of its 2015 marketing and branding initiatives ... new consumer website for Wocketwallet.com earlier this month. ... said, "Our new corporate website naturally showcases our premiere ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... December 11, 2012 A new study published in ... with reductions in the level of cellular adhesion molecules ... immune function. Cell adhesion molecules are the glue ... adhesion molecules would be expected to compromise processes at ...
... Medicine and AstraZeneca, a global biopharmaceutical company, today announced ... to assess the effectiveness of AZD5847, a new test ... HIV co-infection. The study is sponsored by the ... of the U.S. National Institutes of Health. It is ...
... Public opinion on environmental issues such as climate change, ... partisan lines. But new research suggests that environmental messages ... stewardship in terms of fending off threats to the ... may help to narrow the partisan gap. A ...
Cached Biology News:Does the brain become unglued in autism? 2New tuberculosis drug trial begins in South Africa 2Messages that speak to conservatives' morals narrow partisan gap on environment 2Messages that speak to conservatives' morals narrow partisan gap on environment 3
(Date:3/3/2015)... 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... announced it has initiated commissioning activities for its 30,000 ... Sarnia, Ontario , Canada.  Commissioning ... with the facility being in commercial operation in Q3 ... two months and it is carrying out commissioning and ...
(Date:3/3/2015)... , March 2, 2015  Phillip Sharp, Institute ... member of the Department of Biology and the Koch Institute ... Medal at Heritage Day , May 14, at ... of the Othmer Gold Medal since it was first ... "In 1977 Phil Sharp gave the scientific ...
(Date:3/2/2015)... York, NY (PRWEB) March 02, 2015 ... Testing Services industry has experienced robust growth. The ... consumer products, industrial materials, energy resources and other goods, ... and rising government regulation. As a result, IBISWorld forecasts ... of 2.8% to reach $946.8 million over the five-year ...
(Date:3/2/2015)... 2, 2015 VLP Therapeutics, LLC. ("VLP"), ... focusing on the research and development of therapeutic ... based upon a novel and proprietary vaccine technology, ... Impact Grant Award from the Montgomery County Department ... MCDED, is awarded to life sciences companies in ...
Breaking Biology Technology:BioAmber Begins Commissioning of Sarnia Commercial Plant 2BioAmber Begins Commissioning of Sarnia Commercial Plant 3Phillip Sharp to Receive 2015 Othmer Gold Medal 2Phillip Sharp to Receive 2015 Othmer Gold Medal 3Laboratory Testing Services in Canada Industry Market Research Report Now Available from IBISWorld 2Laboratory Testing Services in Canada Industry Market Research Report Now Available from IBISWorld 3VLP Therapeutics Wins the 2015 Life Sciences Impact Grant Award from the Montgomery County Department of Economic Development 2
... Brings Expertise in Single Molecule Fluorescence and ... Nanoscale Measurement ... a developer,of breakthrough nanoscale whole genome imaging platforms for ... of noted biophysicist Paul R. Selvin, Ph.D., to its,Scientific ...
... needs of the medical community; builds on proven ... efficacy and safety of TRELSTAR(R) ... WPI ), a leading specialty pharmaceutical,company, announced today that ... delivery system for TRELSTAR(R) (triptorelin,pamoate for injectable suspension), a palliative ...
... April 30 Computer Sciences,Corporation (NYSE: CSC ... chief,medical officer and vice president of its North ... 10 in Modern Physician and Modern,Healthcare magazines, annual ... in April. Readers from both magazines nominated 7,300,physician ...
Cached Biology Technology:BioNanomatrix Announces Appointment of Paul R. Selvin to Its Scientific Advisory Board 2BioNanomatrix Announces Appointment of Paul R. Selvin to Its Scientific Advisory Board 3FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceutical's TRELSTAR(R) DEPOT and TRELSTAR(R) LA 2FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceutical's TRELSTAR(R) DEPOT and TRELSTAR(R) LA 3FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceutical's TRELSTAR(R) DEPOT and TRELSTAR(R) LA 4FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceutical's TRELSTAR(R) DEPOT and TRELSTAR(R) LA 5CSC's Dr. Robert M. Wah Makes Top 10 in 50 Most Powerful Physician Executives List 2
... Synergistic enzyme mix (Thermoprime Plus DNA ... At least four times higher fidelity than ... of standard Taq DNA polymerase, Amplifies DNA ... PCR, long PCR, PCR for cloning and ...
... Methylation-specific PCR (MSP) is a new ... gene methylation utilizing small amounts of ... initial bisulfite reaction to modify the ... specific primers designed to distinguish methylated ...
... m7G(5')ppp(5')G (Cap Analog) is used for the ... in vitro transcription reactions. Substitution of cap ... GTP in an in vitro transcription reaction ... structure into a large fraction of the ...
... HT is designed for extended ... HT is ideal for applications ... primer extension assays. iEMS Incubator/Shaker ... one-cabinet model, allowing the capacity ...
Biology Products: